MOCingbird Launches New Time-Saving App for Busy Clinicians

PROVIDENCE, R.I., March 12, 2020 /PRNewswire/ — Rhode Island-based MyMOC is thrilled to announce its launched an app for MOCingbird – a platform that allows medical professionals and administrators to easily manage ongoing education requirements needed to maintain their credentials.

In order to treat patients and keep their credentials current, clinicians spend untold hours each year struggling to manage the inconsistent and ever-changing Maintenance of Certification and Continuing Medical Education requirements.

Now, with MOCingbird’s free app, medical professionals are able to harness the power of MOCingbird by tracking their MOC and CME progress on any mobile device. Among the functions, users – after finishing a course – will be able to take a photo of their completion certificate and upload it into the app. In addition, the app serves as an aggregator for online CME courses, allowing clinicians to take courses right in the app.

“By allowing them to make the most of their time, our app is a game-changer for busy doctors like myself who are looking to simplify this necessary, but convoluted process,” said Dr. Ian Madom, a spine surgeon at Ortho Rhode Island and MyMOC co-founder. “Doctors with just minutes to spare can search for bite-sized CME courses, answer a question or two, and knock out some of their requirements while on the go.”

MOCingbird is overseen by MyMOC, Inc., which was founded by Dr. Madom, and Dr. George Fernaine, chief of cardiology at NYU Brooklyn. They came up with the idea while working toward their MBAs at Yale University’s School of Management.

“We’re thrilled to be offering a new tool to members of the healthcare industry,” said MOCingbird CEO Brad Artery. “Clinician burnout is a very real thing. Tools like our MOCingbird app will help doctors and other clinicians add a little balance back to their lives.”

The MOCingbird app is available in the Apple App Store and in Google Play.

About MOCingbird
Founded by busy doctors, it is MOCingbird’s mission to create the easiest place for medical professionals to monitor their MOC and CME requirements. For individual professionals, we develop frictionless solutions to understand, track, document and submit the education requirements for the maintenance of their professional licenses. For medical institutions, we provide meaningful tools to manage a growing medical professional workforce by enabling more efficient uses of resources and more targeted educational opportunities through data-driven professional education oversight and analytics.

Contact:  Nancy Krause
Telephone:  401-793-6547
Email: 235885@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/mocingbird-launches-new-time-saving-app-for-busy-clinicians-301022112.html

SOURCE MOCingbird

Staff

Recent Posts

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

27 minutes ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

27 minutes ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

15 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

15 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

15 hours ago